Sarcoma trials in Thailand

1 trial · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  Where

  Bangkok

  Age

  18 years and over

  People

  140 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07252739 · EU 2025-521939-36-00